Clinical Trial Update: Relapsed and Refractory Hepatoblastoma: A Prospective Registry and Liver Tumor Research Consortium Initiative

View source ↗

Summary

This is a prospective registry and Liver Tumor Research Consortium initiative studying relapsed and refractory hepatoblastoma, currently recruiting participants…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatoblastoma

Snippet

Sponsor: Children's Hospital Medical Center, Cincinnati | Conditions: Relapsed Hepatoblastoma, Refractory Hepatoblastoma | Status: RECRUITING